¼¼°èÀûÀÎ ÇмúÁö°¡ ÁÖ¸ñÇÏ´Â ÀÇ»ç
| Á¦ ¸ñ | Ten-year clinical outcomes in patients with intermediate coronary stenosis according to the combined culprit lesion |
|---|---|
| ¹ßÇ¥³âµµ | 2021 |
| ¹ßÇ¥Áö | CLINICAL CARDIOLOGY |
| Á¦ ¸ñ | Toxocariasis-associated acute perimyocarditis with cardiogenic shock: A case report |
|---|---|
| ¹ßÇ¥³âµµ | 2021 |
| ¹ßÇ¥Áö | American Journal of Case Reports |
| Á¦ ¸ñ | Predictors for high risk carotid plaque in asymptomatic Korean population |
|---|---|
| ¹ßÇ¥³âµµ | 2020 |
| ¹ßÇ¥Áö | Cardiovascular Therapeutics |
| Á¦ ¸ñ | Efficacy and Safety of dual drug-elutinf stents for de novo coronary lesions in South Korea-The EFFECT Trial |
|---|---|
| ¹ßÇ¥³âµµ | 2020 |
| ¹ßÇ¥Áö | Journal of Clinical Medicine |
| Á¦ ¸ñ | Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionThe TAILOR-PCI Randomized Clinical Trial |
|---|---|
| ¹ßÇ¥³âµµ | 2020 |
| ¹ßÇ¥Áö | JAMA |

°Ç¾ç´ëº´¿øÀº 2000³â °³¿øÇÑ Á¾ÇÕ ÀÇ·á±â°üÀ¸·Î º»°ü Áö»ó 11Ãþ ±Ô¸ð¸¦ °®Ãß°í ÀÖ´Ù. ÁßºÎ±Ç ÃÖÃÊ·Î ÀÓ»óº´¸® ÀÚµ¿È ½Ã½ºÅÛ, ó¹æ Àü»êÈ ÇÁ·Î±×·¥ µîÀ» µµÀÔÇß´Ù. 2011³â 11¿ù ¹®À» ¿¬ ¾Ï¼¾ÅÍ´Â Áö»ó 5Ãþ ±Ô¸ð·Î ¾Ï Á¾·ùº°·Î ¿©·¯ Áø·á°ú°¡ ÇùÁøÇÏ´Â ¾ÏÀü¹®ÆÀ Áø·á ½Ã½ºÅÛÀÌ ¸¶·ÃµÅ ÀÖÀ¸¸ç, º»°ü°ú Á÷Á¢ ¿¬°áµÅ ȯÀÚ ¹× º¸È£ÀÚ°¡ Æí¸®ÇÏ°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ´Ù.
´ëÀü±¤¿ª½Ã ¼±¸ °üÀúµ¿·Î 158